Photocure
Less than 1K followers
PHO
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Overview
Investor consensus
Photocure is a medical technology company. The company specializes in photodynamic technology solutions. The solutions are used to treat diseases that cause bladder cancer and HPV. The main markets are dermatology and oncology, where the products are used by hospitals and research institutes worldwide. The company was founded in 1993 and is headquartered in Oslo, Norway.
Read moreMarket cap
-
Turnover
-
Revenue
525.39M
EBIT %
3.88 %
P/E
-
Dividend yield-%
-
All
Press releases
ShowingAll content types
Photocure: The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison
PHO: New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools